Free Trial

STAAR Surgical (STAA) Stock Price, News & Analysis

STAAR Surgical logo
$17.21 +0.36 (+2.16%)
As of 10:46 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About STAAR Surgical Stock (NASDAQ:STAA)

Key Stats

Today's Range
$17.04
$17.49
50-Day Range
$15.35
$25.44
52-Week Range
$13.50
$52.68
Volume
178,890 shs
Average Volume
1.03 million shs
Market Capitalization
$848.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.86
Consensus Rating
Hold

Company Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
94th Percentile Overall Score

STAA MarketRank™: 

STAAR Surgical scored higher than 94% of companies evaluated by MarketBeat, and ranked 62nd out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STAAR Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 8 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    STAAR Surgical has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about STAAR Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for STAAR Surgical are expected to grow by 69.70% in the coming year, from $0.33 to $0.56 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STAAR Surgical is -41.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STAAR Surgical is -41.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    STAAR Surgical has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about STAAR Surgical's valuation and earnings.
  • Percentage of Shares Shorted

    8.00% of the outstanding shares of STAAR Surgical have been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in STAAR Surgical has recently increased by 7.95%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    STAAR Surgical does not currently pay a dividend.

  • Dividend Growth

    STAAR Surgical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.00% of the outstanding shares of STAAR Surgical have been sold short.
  • Short Interest Ratio / Days to Cover

    STAAR Surgical has a short interest ratio ("days to cover") of 6.4.
  • Change versus previous month

    Short interest in STAAR Surgical has recently increased by 7.95%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    STAAR Surgical has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for STAAR Surgical this week, compared to 5 articles on an average week.
  • Search Interest

    Only 13 people have searched for STAA on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, STAAR Surgical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $6,936,904.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.00% of the stock of STAAR Surgical is held by insiders.

  • Percentage Held by Institutions

    96.70% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STAAR Surgical's insider trading history.
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Stock News Headlines

Why Buffett and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Staar Surgical (STAA) was downgraded to a Hold Rating at William Blair
See More Headlines

STAA Stock Analysis - Frequently Asked Questions

STAAR Surgical's stock was trading at $24.29 at the start of the year. Since then, STAA stock has decreased by 29.6% and is now trading at $17.10.
View the best growth stocks for 2025 here
.

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings data on Wednesday, August, 7th. The medical instruments supplier reported $0.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.24 by $0.09. STAAR Surgical's revenue for the quarter was up 7.3% on a year-over-year basis.

STAAR Surgical subsidiaries include Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

STAAR Surgical's top institutional shareholders include Broadwood Capital Inc. (22.01%), Vanguard Group Inc. (11.88%), Resona Asset Management Co. Ltd. (3.04%) and Baillie Gifford & Co. (2.34%). Insiders that own company stock include Broadwood Partners, LP, Caren L Mason, James E Francese, Keith Holliday and Elizabeth Yeu Lin.
View institutional ownership trends
.

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STAAR Surgical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Palo Alto Networks (PANW) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
8/07/2024
Today
2/20/2025
Next Earnings (Estimated)
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:STAA
CUSIP
85231230
Employees
1,115
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$26.86
High Stock Price Target
$53.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+59.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
10 Analysts

Profitability

Net Income
$-20,210,000.00
Pretax Margin
10.26%

Debt

Sales & Book Value

Annual Sales
$313.90 million
Cash Flow
$0.74 per share
Book Value
$7.91 per share

Miscellaneous

Free Float
48,783,000
Market Cap
$830.37 million
Optionable
Optionable
Beta
0.62

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:STAA) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners